Group items tagged

Throughout our lifetime, at some time or another, we can all find ourselves carrying a few extra unwanted pounds! Let's face it, in this day and age gaining weight can be incredibly easy, sometimes all it takes is a break within our willpower, that leads us to give in to temptation! It can happen on our weekly shopping trip, the moment we try our utmost to dodge that sweet however extremely inviting snack aisle, to then suddenly find ourselves failing immensely due to our ever-hungry sweet tooth taking control. We can be sat in front of the TV at home watching our favorite show to then be cursed with the next advert, showcasing the release of the next unhealthy, however extremely delicious sugary creation or we could be on our way to work fuelled on an empty stomach to find our full attention stolen by the latest billboard advertising the next invention in the fast-food chain! Yes, it can be ever so easy to give in to the mouthwatering temptations the world has to offer!

Join us for the prestigious Pharmacy Business Awards 2023, celebrating excellence in community pharmacy. Attend the glittering ceremony in London and witness industry leaders, officials, and ministers. Submit your entry now and showcase the unique services of community pharmacy. Nomination deadline: July 7th, 2023.

Nasofed Anti Viral Nasal Spray, from EM Pharma, is delighted to welcome Dr Sarah Jarvis as medical adviser for its winter colds and flu consumer awareness campaign. Sarah is well known as a trusted and reliable source of medical advice through her various media roles as Resident GP on BBC R2's The Jeremey Vine Show, Good Morning Britain, Channel 5 and ITV News. Says Paul Walsh, EM Pharma Managing Director: "Dr Sarah will be offering advice on how people can best protect themselves and their families against seasonal and year-round viruses, including the use of Nasofed anti viral thixotropic nasal spray as an extra layer of protection particularly in situations of increased viral risk." Dr Sarah adds: "Viruses continue to affect our daily lives, whether that be year-round viruses or more seasonal viruses such as colds and flu and RSV, all of which are expected to be particularly prevalent this year. In situations of increased viral risk, a thixotropic nasal spray delivering anti viral ingredients will help protect you. It's a real step forward in virus prevention, not just for colds and flu, but also year-round viruses."

The Medicines and Healthcare products Regulatory Agency (MHRA) has warned the public to avoid buying pre-filled weight loss pens without a prescription. The warning came after 369 fake Ozempic injections have been seized since January 2023. However, Saxenda pens were obtained by members of the public in the UK through "non-legitimate routes". The health regulator has urged the public to buy the pens after consulting a healthcare professional and with a prescription. Dr Alison Cave, MHRA Chief Safety Officer shared her opinion on the matter, she said: "Buying products such as Ozempic or Saxenda without a prescription, from illegally trading suppliers, significantly increases the risk of receiving something which is either fake or not licensed for use in the UK.

The Medicines and Healthcare products Regulatory Agency (MHRA) has reminded healthcare professionals prescribing aripiprazole to alert patients about its possible side effects, following a rise in the number of reports of gambling disorder associated with the drug. Patients taking aripiprazole, which is used for the treatment of schizophrenia and bipolar disorder, are at risk of developing unusual urges or cravings that they cannot resist, including behaviours such as addictive gambling, excessive eating or spending, or an abnormally high sex drive. The regulator has received 69 reports of gambling or gambling disorder suspected to be caused by aripiprazole in the last 14 years via the Yellow Card Scheme, out of which 32 were received between 1 January and 31 August this year. Alison Cave, MHRA Chief Safety Officer, said: "The number of reports for suspected gambling and other impulsive behaviours associated with aripiprazole are small in comparison to the frequency with which it is prescribed, but the consequences for any patient developing these conditions can be significant."

NHS England has expanded its national bowel screening programme to people aged 54 so that cancers can be detected at an earlier stage when they are easier to treat. As part of the expansion, the health service would be sending a home-testing kit for bowel cancer, known as the Faecal Immunochemical Test (FIT), to thousands more people in the North West. Those who are eligible (aged 54 and over) will now automatically receive the kit every two years by post, enabling them to self-check for blood in stool samples, which can be a sign of bowel cancer. With the expansion of the NHS Bowel Cancer Screening Programme to people aged 54 years, an additional 830,000 people in England will now be eligible for the screening test.

The QuickBooks Desktop Install Diagnostic Tool is a handy application that can help you troubleshoot and fix common problems encountered during the installation of QuickBooks Desktop on your Windows PC. It runs diagnostics, identifies potential issues and suggests solutions to get your installation back You're prepping for a fresh financial year eager to start anew with QuickBooks Desktop. But hold on The installation stumbles throwing cryptic error messages like roadblocks. Frustration mounts as you scour forums and support pages piecing together solutions that may or may not work.Enter the QuickBooks Desktop Install Diagnostic Tool your knight in shining armor. This free built-in tool within the QuickBooks Tool Hub is like a skilled mechanic for your installation woes. It meticulously scans your system pinpointing the exact gremlins causing the trouble.Then No more days of battling cryptic errors alone. The Install Diagnostic Tool empowers you to take control transforming installation hiccups into a distant memory. It's like having a friendly tech-savvy sidekick alongside you ensuring your QuickBooks journey starts smoothly and stays that way. So, the next time installation throws a curveball don't panic. Just grab the Install Diagnostic Tool and witness the magic of a swift painless resolution. It's time to ditch the installation woes and get back to focusing on what matters - managing your finances with confidence.

Adderall is a trading name for the combination drug that includes 4 types of amphetamine salts (Amphetamine aspartate, dextroamphetamine sulfate, dextroamphetamine saccharate, and amphetamine sulfate). In this, the two main ingredients Amphetamine and dextroamphetamine are the central nervous system stimulants that help to pay attention, stay focused, and control uncontrollable behavioral activities. Both Adderall vs Methylphenidate (commonly known as Ritalin) are stimulant medications prescribed for attention deficit hyperactivity disorder (ADHD). While they share the same goal of improving focus, attention, and reducing impulsivity, key differences exist in their composition, action, and side effects. Choosing the right one requires understanding these nuances and consulting a healthcare professional. Chemical Composition: Adderall: A brand name for a mixture of amphetamines (amphetamine and dextroamphetamine). These directly stimulate the central nervous system, increasing dopamine and norepinephrine levels. Methylphenidate: Not an amphetamine, but a psychostimulant that works by blocking the reuptake of dopamine and norepinephrine, essentially making them more available in the brain. Side Effects: Adderall: More likely to cause side effects like anxiety, insomnia, decreased appetite, headaches, and heart palpitations. Methylphenidate: More prone to causing side effects like nervousness, stomach upset, tics, and mood swings.

Great news for multiple sclerosis patients! The NHS has introduced a new 10-minute injection that can slow the progression of disability while reducing hospital treatment time by over 90 per cent. Currently, MS patients in England receive ocrelizumab (Ocrevus), manufactured by Roche, through twice-yearly intravenous (IV) infusions that can last up to four hours. Now, around 9,000 NHS patients in England will be able to receive the drug via a quick 'under-the-skin' twice-yearly injection. It takes just ten minutes, enabling patients to spend less time in the hospital receiving treatment. This roll-out follows approval from the Medicines and Healthcare products Regulatory Agency (MHRA), making the NHS one of the first healthcare systems worldwide to offer this new MS injection. Drug stocks are expected to be available in the coming weeks.